Cogent Biosciences, Inc.
COGT
$34.29
-$0.24-0.70%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 866.38M | 900.77M | 390.89M | 237.85M | 245.66M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 11.43M | 9.59M | 6.35M | 7.16M | 7.22M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 877.80M | 910.36M | 397.24M | 245.01M | 252.88M |
|
|
|||||
| Total Current Assets | 877.80M | 910.36M | 397.24M | 245.01M | 252.88M |
| Net Property, Plant & Equipment | 22.85M | 23.54M | 23.87M | 24.95M | 26.05M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.36M | 3.72M | 4.82M | 4.86M | 4.86M |
| Total Assets | 903.01M | 937.61M | 425.93M | 274.82M | 283.80M |
|
|
|||||
| Total Accounts Payable | 13.74M | 9.50M | 16.03M | 16.63M | 14.15M |
| Total Accrued Expenses | 41.01M | 46.16M | 43.23M | 38.87M | 33.07M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.38M | 1.55M | 1.71M | 1.66M | 1.61M |
| Total Finance Division Other Current Liabilities | 1.85M | 6.75M | 1.29M | 1.27M | 484.00K |
| Total Other Current Liabilities | 1.85M | 6.75M | 1.29M | 1.27M | 484.00K |
| Total Current Liabilities | 57.98M | 63.95M | 62.25M | 58.42M | 49.32M |
|
|
|||||
| Total Current Liabilities | 57.98M | 63.95M | 62.25M | 58.42M | 49.32M |
| Long-Term Debt | 223.17M | 222.90M | 44.25M | 43.95M | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 14.10M | 14.36M | 14.60M | 15.05M | 15.48M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 62.00K | 33.00K | 2.37M | 2.36M | 5.00K |
| Total Liabilities | 295.31M | 301.24M | 123.47M | 119.78M | 64.80M |
|
|
|||||
| Common Stock & APIC | 1.83B | 1.74B | 1.28B | 1.05B | 1.04B |
| Retained Earnings | -1.29B | -1.19B | -1.09B | -1.00B | -931.47M |
| Treasury Stock & Other | -415.00K | 355.00K | 208.00K | 13.00K | 164.00K |
| Total Common Equity | 542.94M | 546.98M | 194.55M | 47.12M | 110.83M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 64.75M | 89.39M | 107.92M | 107.92M | 108.17M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 64.75M | 89.39M | 107.92M | 107.92M | 108.17M |
|
|
|||||
| Total Common Equity | 542.94M | 546.98M | 194.55M | 47.12M | 110.83M |
| Total Preferred Equity | 64.75M | 89.39M | 107.92M | 107.92M | 108.17M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 607.69M | 636.37M | 302.46M | 155.04M | 219.00M |
|
|
|||||